Marker Therapeutics (MRKR) Price to Book (2010 - 2026)

Marker Therapeutics (MRKR) has reported Price to Book for 17 consecutive years, with 2.02 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book rose 22.44% year-over-year to 2.02 in Q2 2026; TTM through Jun 2026 was 2.02, a 22.44% increase from a year earlier, with the FY2025 full-year figure at 1.48, down 17.38% from the prior year.
• Price to Book was 2.02 for Q2 2026 at Marker Therapeutics, up from 1.57 in the prior quarter.
• Over five years, Price to Book peaked at 4.98 in Q2 2024 and troughed at 0.39 in Q1 2023.
• A 5-year average of 1.89 and a median of 1.53 in 2026 frame the typical range for Price to Book.
• Across the five-year window, Price to Book soared 726.86% in 2024 and sank 76.01% in 2025, its largest moves.
• Over 5 years, Price to Book stood at 1.16 in 2022, then surged by 201.05% to 3.48 in 2023, then sank by 48.52% to 1.79 in 2024, then declined by 17.38% to 1.48 in 2025, then jumped by 36.22% to 2.02 in 2026.
• The last three Price to Book figures came in at 2.02 (Q2 2026), 1.57 (Q1 2026), and 1.48 (Q4 2025), per Business Quant data.